On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
TuesdayJun 28, 2022 9:00 am

Nowigence Inc. (NOWG) User Case Studies Show Depth, Breadth of Pluaris App’s Power

Nowigence’s Pluaris app can instantaneously distill knowledge buried in narrative-intensive documents from both public and private sources Pluaris case studies illustrate different ways innovative platform can be used Nowigence is focused on simplifying the challenges of learning, with so much information available today Nowigence (OTCQB: NOWG)’s Pluaris(TM) — a comprehensive, ready-to-use artificial intelligence (“AI”) platform — is designed to build intelligence quickly. The cloud-based, knowledge-management tool supports users who are looking to advance their competence and competitiveness by gathering key information that can accelerate the pace of problem solving and decision making. According to the company, Pluaris “mimics the way…

Continue Reading

MondayJun 27, 2022 12:45 pm

Advanced Container Technologies Inc. (ACTX) GrowPods Strengthen Company’s Position in Growing Multibillion-Dollar Market

The global indoor farming market projected to grow from $26.5 billion in 2021 to $62 billion by 2030 Report indicates that United States holds major share in terms of revenue in North America indoor farming market Grow Pods offered through ACTX provide a controlled environment, ability to grow year-round The newest projections for the global indoor farming sector are in, and the numbers bode well for Advanced Container Technologies (OTC: ACTX). ACTX is the exclusive U.S. distributor of Grow Pods, environmentally controlled micro-farms that allow cultivation of ultra-clean crops all year long.  “The study undertaken by Astute Analytica foresees a tremendous growth in revenue of the…

Continue Reading

MondayJun 27, 2022 12:00 pm

Cepton, Inc. (NASDAQ: CPTN), a Leader in Lidar, Continues to Execute on its Core Strategic Milestones Across Automotive & Smart Infrastructure

Cepton develops lidar sensors for ADAS and autonomous driving, and has been awarded the largest lidar production contract to date with products set to debut next year across General Motor’s Ultra Cruise ADAS platform Award covers 4 target vehicle models in 2023, 4+ models in 2024, and an anticipated 4+ models in 2025 with Cadillac being the first to introduce the Ultra Cruise technology Cepton’s proprietary MMT(R) technology provides a highly competitive price for performance and reliability Founder-led, visionary management team with substantial “skin in the game” Since becoming public in early 2022, Cepton (NASDAQ: CPTN) has not deviated from…

Continue Reading

MondayJun 27, 2022 11:15 am

Golden Matrix Group Inc. (NASDAQ: GMGI) Grows Quarterly Net Income by Over 359% Yoy, Sees Margins Widen by Nearly 43%

Golden Matrix Group recently reported its 15th consecutive quarter of profitability GMGI’s second quarter revenues rose 221% YoY with net income expanding by upwards of 359% YoY GMGI attributed the rise in revenues to the added contribution from UK-based competition company, RKingsCompetitions Ltd, which Golden Matrix acquired in November 2021 Management expressed their continued optimism on GMGI’s future prospects, with the company’s B2B and B2C verticals both showing robust growth  Fifteen consecutive quarters of profitability is a remarkable feat; even Amazon, the world's largest e-commerce operator, reported a net loss over the past three months. Moreover, Golden Matrix Group (NASDAQ:…

Continue Reading

MondayJun 27, 2022 10:30 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Expands Reach of its Drug Delivery Technology Through Newly Inked Agreements with Beverage Developer BevNology

Drug delivery technology innovator Lexaria Bioscience has developed a patented technology showing superiority in animal and human testing as a means of improving existing drug brands’ performance and establishing new solutions for unmet medical needs The company recently announced agreements with beverage developer BevNology to expand production capabilities for Lexaria's own growing list of B2B clientele and empowering BevNology to offer DehydraTECH products with active ingredients derived from hemp including CBD under BevNology and partnered brands  The technology is called DehydraTECH — improving the way active pharmaceutical ingredients (“APIs”) enter the bloodstream by promoting more effective oral delivery   Lexaria also…

Continue Reading

MondayJun 27, 2022 9:45 am

Odyssey Health, Inc. (ODYY) Targeting Achievement of Important Milestones, as It Progresses Clinical Trials of Novel Concussion Drug

Odyssey Health is focused on developing life-saving medical products and pharmaceutical assets that offer a technological and clinical advantage The company is developing the CardioMap Heart Monitoring and Screening Device and the Save-a-Life choking rescue device  Its drug-device combination is intended to get PRV-002, Odyssey’s novel treatment for concussion, to the brain rapidly after concussion In an interview with RedChip Companies CEO Dave Gentry, Odyssey CEO Michael Redmond outlined the timelines under which the company is operating as it eyes the commercialization of its novel drug candidate Medical company Odyssey Health (OTC: ODYY) is working to provide life-saving medical solutions…

Continue Reading

MondayJun 27, 2022 9:00 am

Home Bistro Inc.’s (HBIS) Model Meals Brand Unveils New Subscription-Based Plan

New meal plan offering includes three meals a day (breakfast, lunch and dinner) up to five days per week Model Meals brand is optimal for providing seamless customer experience, substantially increased customer lifetime value Move provides opportunity to explore subscription model with other HBIS components, says CEO Home Bistro (OTC: HBIS), a leading online meal-delivery platform that offers exclusive celebrity chef-inspired, gourmet and lifestyle ready-made meals, is strengthening its commitment to offer exclusive celebrity-chef-inspired, ready-made meals by launching its first subscription-based offering for its Model Meals brand (https://ibn.fm/9wDv9). The new plan offering includes three meals a day (breakfast, lunch and…

Continue Reading

MondayJun 27, 2022 2:15 am

Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Reports Initial Results from Feasibility Study

Study indicates that ketamine-induced changes in functional connectivity last for several days after administration of the substance Kernel Flow gathers real-time functional brain activity during clinical and research studies evaluating psychedelic-based therapeutics Technology is “precisely what we need to accelerate the development of psychedelics into therapeutics,” says Cybin CEO New data confirms Cybin’s (NEO: CYBN) (NYSE American: CYBN) focus on and commitment to progressing psychedelics to therapeutics. The company’s feasibility study using Kernel Flow confirms the device’s ability to successfully measure the neuro-effect of ketamine (https://ibn.fm/blLwT), based on study results presented at the PSYCH Symposium in London. Cybin has announced that…

Continue Reading

MondayJun 27, 2022 1:30 am

Silo Pharma Inc. (SILO) Takes Aim at Alzheimer’s Disease

In October 2021, Silo Pharma (OTCQB: SILO) entered into a sponsored research agreement (“SRA”) with Columbia University to investigate and advance psychedelic therapeutics for Alzheimer's Disease (“AD”).  SRA’s grant Silo access to world-class research facilities to sponsor potential life-changing research while offering Silo licensing opportunities for groundbreaking psychedelic remedies.  Columbia University Irving Medical Center (“CUIMC”), an “internationally recognized leader” in research and therapeutic development, partnered with Silo to study psychedelics’ ability to improve, slow, or even reverse functional decline and memory loss associated with Alzheimer's disease. Associate Professor of Clinical Neurobiology, Dr. Christine Ann Denny, helming the research for Silo,…

Continue Reading

FridayJun 24, 2022 12:45 pm

Sustain SoCal Presents the Driving Mobility 9 Event

Sustain Southern California (“Sustain SoCal”) accelerates cleantech economic growth and sustainability initiatives through innovation, collaboration, and education. Sustain SoCal is hosting Driving Mobility - the 9th Annual Transportation Conference. This year’s event will feature succinct presentations by leading c-suite executives, senior management, and industry experts from public sector organizations. Invited speakers will share their perspectives on a multitude of issues, including electrification, V2X, hydrogen/fuel cell, OEM and investor trends, connected vehicles, mobility as a service, incentives, policy, legislation, and sustainability. Mobility and transportation experts, representatives of local and state authorities, potential investors from private equity and venture capital, experts from the battery storage…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered